ask="2.90"
ask_size="500"
average_daily_volume="189537"
bid="N/A"
bid_size="N/A"
book_value="0.56"
change="+0.00"
change_from_200_day_moving_average="0.40"
change_from_50_day_moving_average="0.26"
change_from_52_week_high="-1.04"
change_From_52_week_low="0.77"
change_in_percent="+0.00%"
close="2.83"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.31"
ebitda="-5.76M"
eps_estimate_current_year="-0.34"
eps_estimate_next_quarter="-0.21"
eps_estimate_next_year="-0.91"
ex_dividend_date="N/A"
float_shares="16233000"
high="2.86"
high_52_weeks="3.87"
last_trade_date="1/27/2017"
last_trade_price="2.83"
last_trade_size="100"
last_trade_time="3:59pm"
low="2.75"
low_52_weeks="2.06"
market_capitalization="52.88M"
moving_average_200_day="2.43"
moving_average_50_day="2.57"
name="Brainstorm Cell Therapeutics In"
notes="N/A"
one_year_target_price="6.00"
open="2.85"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+16.46%"
percent_change_from_50_day_moving_average="+9.99%"
percent_change_from_52_week_high="-26.87%"
percent_change_from_52_week_low="+37.38%"
previous_close="2.83"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="5.03"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="18687000"
short_ratio="1.38"
stock_exchange="NCM"
symbol="BCLI"
volume="89879"
weeks_range_52="2.06 - 3.87"
